Robert S. Kahn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Robert S. Kahn has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Adam J. Spanier
Department of Pediatrics, University of Maryland, School of Medicine (AJ Spanier), Baltimore, Md
1 shared publication Alexandr Vilimovskij
F. Hoffmann-La Roche Ltd, Basel, Switzerland
1 shared publication- Amal Assa’ad
Cincinnati Children’s Hospital Medical Center, Cincinnati, USA
1 shared publication - Amos Baruch
OMNI Biomarker Development, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA
1 shared publication Anette Nilsson
Region Jönköping County
1 shared publication- Bruce Perrin Lanphear
Faculty of Health Sciences, Simon Fraser University, Vancouver, Canada
1 shared publication
Latest Publications
- Open Access
- 7 November 2021
- Published by BMJ
- Vol. 10 (Suppl 2) , A11-A13
11 Getting it right, right now, while building services ready for future health needs of populations
Background Improving wellbeing outcomes of children has been a joint focus of work for three of IHI’s strategic partners in recent years. They are benefitting from collaborating to support the acceleration of work that they have in common and working to close the equity related gap for children and young people in each of their localities. Although each locality is unique, these partners have found the collaboration of learning powerful for each context, and that they have more in common than sets them apart. Objectives These large scale efforts are ambitious and focused; identifying the children who require support; identifying interventions that will deliver improved outcomes; working collaboratively across sectors and professional groups to provide services that work for the community; and applying a rigorous improvement method to support implementation of change. Methods Service redesign approaches; co-production with children and community members; multi - disciplinary working across boundaries; the science of improvement to test, measure and implement changes. Results Achieving high impact results at scale is the ambition of these partners, however, with the knowledge that population health outcomes are generational and can take many years to realise their full potential; these 3 partners describe impactful work on localities with smaller groups, iteratively learning for scalable work. In early years development, in schools and community centers, qualitative and quantitative data describes the journey that these partners are travelling (figures 1–5). It is a story of improvement science in practice and service redesign modelling with children and young people at the center of all they do. Conclusions These ambitious Strategic Partners have benefitted from a collaborative and virtual learning environment where the exploration and sharing of methods, theories, evidence and practice has supported this global enquiry into child wellbeing, equity and equality issues for disadvantaged communities, and the application of improvement science methods to accelerate change today and for the future.
- 7 November 2021
- Published by BMJ
- Vol. 10 (Suppl 2) , A11-A13
Open Access11 Getting it right, right now, while building services ready for future health needs of populations
Background Improving wellbeing outcomes of children has been a joint focus of work for three of IHI’s strategic partners in recent years. They are benefitting from collaborating to support the acceleration of work that they have in common and working to close the equity related gap for children and young people in each of their localities. Although each locality is unique, these partners have found the collaboration of learning powerful for each context, and that they have more in common than sets them apart. Objectives These large scale efforts are ambitious and focused; identifying the children who require support; identifying interventions that will deliver improved outcomes; working collaboratively across sectors and professional groups to provide services that work for the community; and applying a rigorous improvement method to support implementation of change. Methods Service redesign approaches; co-production with children and community members; multi - disciplinary working across boundaries; the science of improvement to test, measure and implement changes. Results Achieving high impact results at scale is the ambition of these partners, however, with the knowledge that population health outcomes are generational and can take many years to realise their full potential; these 3 partners describe impactful work on localities with smaller groups, iteratively learning for scalable work. In early years development, in schools and community centers, qualitative and quantitative data describes the journey that these partners are travelling (figures 1–5). It is a story of improvement science in practice and service redesign modelling with children and young people at the center of all they do. Conclusions These ambitious Strategic Partners have benefitted from a collaborative and virtual learning environment where the exploration and sharing of methods, theories, evidence and practice has supported this global enquiry into child wellbeing, equity and equality issues for disadvantaged communities, and the application of improvement science methods to accelerate change today and for the future.
- Open Access
- 21 November 2017
- Published by Springer Nature
- p. 499-520
Health Disparities: A Life Course Health Development Perspective and Future Research Directions
Historically, research examining health status disparities between members in different socioeconomic status and racial/ethnic groups often focused on adults and the concurrent lifestyle factors that might explain health differentials. Recent years have witnessed an explosion of interest in the developmental origins of adult health and disease, and life course-oriented research has proliferated across the social, biological, and health sciences. This chapter describes how an integrated life course health development framework can be applied to advance our understanding of the dynamic and multilevel processes contributing to health disparities across lifetimes and even generations. Examples of recent research that has examined health status disparities from a life course perspective are provided, and research gaps and challenges are reviewed. The chapter concludes with a set of recommendations for a more strategic and responsive life course-informed research agenda that not only can fill in gaps in current knowledge, but also pave the way for the translation of this knowledge into improvement in practice, programs, and policy aimed at alleviating health disparities.
- 21 November 2017
- Published by Springer Nature
- p. 499-520
Open AccessHealth Disparities: A Life Course Health Development Perspective and Future Research Directions
Historically, research examining health status disparities between members in different socioeconomic status and racial/ethnic groups often focused on adults and the concurrent lifestyle factors that might explain health differentials. Recent years have witnessed an explosion of interest in the developmental origins of adult health and disease, and life course-oriented research has proliferated across the social, biological, and health sciences. This chapter describes how an integrated life course health development framework can be applied to advance our understanding of the dynamic and multilevel processes contributing to health disparities across lifetimes and even generations. Examples of recent research that has examined health status disparities from a life course perspective are provided, and research gaps and challenges are reviewed. The chapter concludes with a set of recommendations for a more strategic and responsive life course-informed research agenda that not only can fill in gaps in current knowledge, but also pave the way for the translation of this knowledge into improvement in practice, programs, and policy aimed at alleviating health disparities.
- 1 August 2017
- Published by Elsevier in Academic Pediatrics
- Vol. 17 (6) , 607-613
Development of a Child Health Learning Network to Improve Population Health Outcomes; Presented in Honor of Dr Robert Haggerty
- 1 August 2017
- Published by Elsevier in Academic Pediatrics
- Vol. 17 (6) , 607-613
Development of a Child Health Learning Network to Improve Population Health Outcomes; Presented in Honor of Dr Robert Haggerty
- 1 May 2017
- Published by Elsevier in The American Journal of Cardiology
- Vol. 119 (10) , 1576-1583
Effects of RG7652, a Monoclonal Antibody Against PCSK9, on LDL-C, LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or With Established Coronary Heart Disease (from the Phase 2 EQUATOR Study)
- 1 May 2017
- Published by Elsevier in The American Journal of Cardiology
- Vol. 119 (10) , 1576-1583
Effects of RG7652, a Monoclonal Antibody Against PCSK9, on LDL-C, LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or With Established Coronary Heart Disease (from the Phase 2 EQUATOR Study)
- 1 March 2014
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 69 (3) , 125-126
Dosage Effect of Prenatal Home Visiting on Pregnancy Outcomes in At-Risk, First-Time Mothers
In the United States, the current preterm birth rate is 12% or 500,000 infants annually. A home visiting program is one strategy to improve maternal-child health outcomes. An important aspect of home visiting is the duration of enrollment and the number of home visits, or a so-called “dosage effect.” The goal of this retrospective cohort study was to evaluate the effect of dosage of home visiting during the first and second trimesters on pregnancy outcomes. The dosage effect was assessed in at-risk, first-time mothers from 2007 to 2010. Eligible mothers had at least 1 risk characteristic: unmarried, low income, younger than 18 years, or suboptimal prenatal care. Outcomes were preterm birth and birth weight, that is, small for gestational age (SGA) versus appropriate or large for gestational age. The primary predictor was dosage of prenatal home visiting. Intensity of participation was measured as the number of completed prenatal home visits. From 2330 women, 918 prenatally enrolled first-time mothers had a singleton pregnancy; 441 enrolled by 26 weeks’ gestation and were included in the final cohort. Mean maternal age was 20 years, and mean gestational age at enrollment was 18.9 weeks. The preterm birth rate was 10.9%, and 17.9% of infants were SGA. The number of completed prenatal home visits ranged from 1 to 26, with fewer visits completed before 26 weeks (range, 1–16). In bivariate analyses, preterm birth was not significantly associated with gestational age at enrollment or number of home visits before 26 weeks. Compared with women delivering at full term, more women delivering preterm had a history of prior poor pregnancy outcome (25.0% vs 10.7%), hypertension/preeclampsia (27.1% vs 12.0%), and disorders of placentation (4.2% vs 0.5%), all P < 0.05. Women delivering an SGA infant did not differ significantly from women with non-SGA infants in mean gestational age at enrollment or number of total prenatal home visits. Timing of enrollment in home visiting was not independently associated with preterm birth, whereas the number of home visits before 26 weeks was statistically significant. Compared with the reference group of 3 home visits or less, completion of 8 or more home visits by 26 weeks was associated with an adjusted odds ratio of 0.38 for preterm birth (95% confidence interval [CI], 0.16–0.87). Compared with the reference group, having 12 or more prenatal home visits was significantly associated with a 0.32 hazard ratio of SGA status (95% CI, 0.15–0.68). Maternal age younger than 18 years was significantly associated with SGA status compared with age older than 18 years (hazard ratio, 1.37; 95% CI, 1.06–1.76). Given the importance of preterm birth to pediatric morbidity and health care costs, further conceptualization and measurements of prenatal provision of home visits are crucial. As prenatal programs expand for at-risk women, enrollment early in pregnancy and a high intensity of home visits during the first and second trimesters are important to achieve the goals of reducing preterm births and SGA status.
- 1 March 2014
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 69 (3) , 125-126
Dosage Effect of Prenatal Home Visiting on Pregnancy Outcomes in At-Risk, First-Time Mothers
In the United States, the current preterm birth rate is 12% or 500,000 infants annually. A home visiting program is one strategy to improve maternal-child health outcomes. An important aspect of home visiting is the duration of enrollment and the number of home visits, or a so-called “dosage effect.” The goal of this retrospective cohort study was to evaluate the effect of dosage of home visiting during the first and second trimesters on pregnancy outcomes. The dosage effect was assessed in at-risk, first-time mothers from 2007 to 2010. Eligible mothers had at least 1 risk characteristic: unmarried, low income, younger than 18 years, or suboptimal prenatal care. Outcomes were preterm birth and birth weight, that is, small for gestational age (SGA) versus appropriate or large for gestational age. The primary predictor was dosage of prenatal home visiting. Intensity of participation was measured as the number of completed prenatal home visits. From 2330 women, 918 prenatally enrolled first-time mothers had a singleton pregnancy; 441 enrolled by 26 weeks’ gestation and were included in the final cohort. Mean maternal age was 20 years, and mean gestational age at enrollment was 18.9 weeks. The preterm birth rate was 10.9%, and 17.9% of infants were SGA. The number of completed prenatal home visits ranged from 1 to 26, with fewer visits completed before 26 weeks (range, 1–16). In bivariate analyses, preterm birth was not significantly associated with gestational age at enrollment or number of home visits before 26 weeks. Compared with women delivering at full term, more women delivering preterm had a history of prior poor pregnancy outcome (25.0% vs 10.7%), hypertension/preeclampsia (27.1% vs 12.0%), and disorders of placentation (4.2% vs 0.5%), all P < 0.05. Women delivering an SGA infant did not differ significantly from women with non-SGA infants in mean gestational age at enrollment or number of total prenatal home visits. Timing of enrollment in home visiting was not independently associated with preterm birth, whereas the number of home visits before 26 weeks was statistically significant. Compared with the reference group of 3 home visits or less, completion of 8 or more home visits by 26 weeks was associated with an adjusted odds ratio of 0.38 for preterm birth (95% confidence interval [CI], 0.16–0.87). Compared with the reference group, having 12 or more prenatal home visits was significantly associated with a 0.32 hazard ratio of SGA status (95% CI, 0.15–0.68). Maternal age younger than 18 years was significantly associated with SGA status compared with age older than 18 years (hazard ratio, 1.37; 95% CI, 1.06–1.76). Given the importance of preterm birth to pediatric morbidity and health care costs, further conceptualization and measurements of prenatal provision of home visits are crucial. As prenatal programs expand for at-risk women, enrollment early in pregnancy and a high intensity of home visits during the first and second trimesters are important to achieve the goals of reducing preterm births and SGA status.
- 1 March 2012
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 108 (3) , 135-140
Mouse sensitization as an independent risk factor for asthma morbidity
- 1 March 2012
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 108 (3) , 135-140
Mouse sensitization as an independent risk factor for asthma morbidity
- Open Access
- 6 June 2011
- Published by Elsevier in The Journal of Pediatrics
- Vol. 159 (5) , 776-782
Comparison of Biomarkers and Parent Report of Tobacco Exposure to Predict Wheeze
- 6 June 2011
- Published by Elsevier in The Journal of Pediatrics
- Vol. 159 (5) , 776-782
Open AccessComparison of Biomarkers and Parent Report of Tobacco Exposure to Predict Wheeze